Suggested potential sarcopenia biomarkers are myostatin (MSTN), insulin-like growth factor 1 (IGF-I), C-terminal agrin fragment (CAF), interleukin-6 (IL-6), tumor necrosis factor alpha (TNF-α), and vitamin D [9,10,11]. This evidence concerns the gene MSTN and sarcopenia.